Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Operating Margin (2021 - 2025)

Verrica Pharmaceuticals (VRCA) has 5 years of Operating Margin data on record, last reported at 141.24% in Q4 2025.

  • For Q4 2025, Operating Margin fell 49581.0% year-over-year to 141.24%; the TTM value through Dec 2025 reached 34.25%, up 83700.0%, while the annual FY2025 figure was 34.25%, 83700.0% up from the prior year.
  • Operating Margin reached 141.24% in Q4 2025 per VRCA's latest filing, down from 11.34% in the prior quarter.
  • Across five years, Operating Margin topped out at 354.57% in Q4 2024 and bottomed at 19159.46% in Q1 2023.
  • Average Operating Margin over 5 years is 2621.48%, with a median of 486.12% recorded in 2024.
  • Peak YoY movement for Operating Margin: tumbled -1744020bps in 2023, then skyrocketed 1867334bps in 2024.
  • A 5-year view of Operating Margin shows it stood at 0.5% in 2021, then plummeted by -1826865bps to 9133.82% in 2022, then soared by 87bps to 1163.78% in 2023, then skyrocketed by 130bps to 354.57% in 2024, then plummeted by -140bps to 141.24% in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Margin were 141.24% in Q4 2025, 11.34% in Q3 2025, and 11.89% in Q2 2025.